Exact Mass: 337.1539

Exact Mass Matches: 337.1539

Found 79 metabolites which its exact mass value is equals to given mass value 337.1539, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Furylacryloylalanyllysine

6-Amino-2-[(2-{[3-(furan-2-yl)-1-hydroxyprop-2-en-1-ylidene]amino}-1-hydroxypropylidene)amino]hexanoate

C16H23N3O5 (337.1638)


   

H-D-Tyr-val-gly-OH

2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylbutylidene)amino]acetate

C16H23N3O5 (337.1638)


   

Oclacitinib

N-Methyl-1-{4-[methyl({7h-pyrrolo[2,3-D]pyrimidin-4-yl})amino]cyclohexyl}methanesulphonamide

C15H23N5O2S (337.1572)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor

   

Ractopamine hydrochloride

4-Hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Leanness enhancer for pigs. Approved for use in the USA

   

3alpha-(3,4,5-Trimethoxybenzoyloxy)nortropan-6beta-ol

3alpha-(3,4,5-Trimethoxybenzoyloxy)nortropan-6beta-ol

C17H23NO6 (337.1525)


   
   

(Xi)-beta-D-Glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitril|(Xi)-beta-D-glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitrile

(Xi)-beta-D-Glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitril|(Xi)-beta-D-glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitrile

C17H23NO6 (337.1525)


   

4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-5-oxo-5-phenylmethoxypentanoic acid

4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-5-oxo-5-phenylmethoxypentanoic acid

C17H23NO6 (337.1525)


   

1,4,9-trihydroxynonene mercapturic acid

1,4,9-trihydroxynonene mercapturic acid

C14H27NO6S (337.1559)


   
   
   
   
   
   
   
   
   
   
   

Desmethylpirenzepine

Desmethylpirenzepine

C18H19N5O2 (337.1539)


   
   
   
   
   

2,6-Bis(4-Methylphenyl)-4-phenylpyrylium

2,6-Bis(4-Methylphenyl)-4-phenylpyrylium

C25H21O+ (337.1592)


   

tert-butyl 4-(3-methoxy-4-nitrophenyl)piperazine-1-carboxylate

tert-butyl 4-(3-methoxy-4-nitrophenyl)piperazine-1-carboxylate

C16H23N3O5 (337.1638)


   

Boc-D-glutamic acid α-benzylester

Boc-D-glutamic acid α-benzylester

C17H23NO6 (337.1525)


   

Boc-β-homo-Asp(OBzl)-OH

Boc-β-homo-Asp(OBzl)-OH

C17H23NO6 (337.1525)


   

N-Cbz-L-Glutamic acid 5-tert-butyl ester

N-Cbz-L-Glutamic acid 5-tert-butyl ester

C17H23NO6 (337.1525)


   

Boc-L-Glutamic acid 5-benzylester

Boc-L-Glutamic acid 5-benzylester

C17H23NO6 (337.1525)


   

Boc-D-Glutamic acid 5-benzylester

Boc-D-Glutamic acid 5-benzylester

C17H23NO6 (337.1525)


   

z-β-glu(otbu)-oh

z-β-glu(otbu)-oh

C17H23NO6 (337.1525)


   

N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)prop-2-enamide

N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)prop-2-enamide

C17H23NO6 (337.1525)


   

Z-D-Glu(OtBu)-OH

Z-D-Glu(OtBu)-OH

C17H23NO6 (337.1525)


   

H-D-Tyr-Val-Gly-OH

2-[[2-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]acetic acid

C16H23N3O5 (337.1638)


   

1-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SULFONYL)PYRROLIDINE

1-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SULFONYL)PYRROLIDINE

C16H24BNO4S (337.1519)


   

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

C24H19NO (337.1467)


   

1-O-tert-butyl 4-O-methyl 2-(phenylmethoxycarbonylamino)butanedioate

1-O-tert-butyl 4-O-methyl 2-(phenylmethoxycarbonylamino)butanedioate

C17H23NO6 (337.1525)


   

Dobutamine hydrochloride

Dobutamine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Dobutamine hydrochloride is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine hydrochloride is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion[1][2][3][4].

   
   
   

Z-Asp(OtBu)-Ome

Z-Asp(OtBu)-Ome

C17H23NO6 (337.1525)


   

Boc-L-glutamic acid 1-benzyl ester

Boc-L-glutamic acid 1-benzyl ester

C17H23NO6 (337.1525)


   

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

C16H21BFNO5 (337.1497)


   

tert-Butyl 4-(5-methoxy-2-nitrophenyl)piperazine-1-carboxylate

tert-Butyl 4-(5-methoxy-2-nitrophenyl)piperazine-1-carboxylate

C16H23N3O5 (337.1638)


   

Isoxsuprine hydrochloride

Isoxsuprine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.

   

6-[(Z)-2-(2,5-dimethoxyphenyl)ethenyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine

6-[(Z)-2-(2,5-dimethoxyphenyl)ethenyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine

C18H19N5O2 (337.1539)


   

N4,N6-dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine

N4,N6-dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine

C15H23N5O2S (337.1572)


GS39783 is a positive allosteric modulator (PAM) of GABABR. Positive modulation of the GABABR can be used for the research of Nicotine addiction[1].

   

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

C18H24ClNO3 (337.1445)


   

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

C16H23N3O3S (337.146)


   
   
   

(2S)-N-[(3Z)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxoimidazolidin-1-YL)phenyl]propanamide

(2S)-N-[(3Z)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxoimidazolidin-1-YL)phenyl]propanamide

C18H19N5O2 (337.1539)


   

Ractopamine Hydrochloride

Ractopamine Hydrochloride

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

Oclacitinib

Oclacitinib

C15H23N5O2S (337.1572)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor

   

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

C20H21N2O3- (337.1552)


   
   

5-amino-1-[(3-methoxyphenyl)methyl]-N-(4-methylphenyl)-4-triazolecarboxamide

5-amino-1-[(3-methoxyphenyl)methyl]-N-(4-methylphenyl)-4-triazolecarboxamide

C18H19N5O2 (337.1539)


   

(1Z)-1-[(5S)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}-2,4-dioxopyrrolidin-3-ylidene]ethanolate

(1Z)-1-[(5S)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}-2,4-dioxopyrrolidin-3-ylidene]ethanolate

C20H21N2O3- (337.1552)


   
   
   
   
   

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

C18H24ClNO3 (337.1445)


   
   
   
   
   
   
   

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

Nonanal O-[(pentafluorophenyl)methyl]oxime

Nonanal O-[(pentafluorophenyl)methyl]oxime

C16H20F5NO (337.1465)


   

1-Acetoxy-3-(N-acetyl-2-acetoxyethylamino)-5-methoxy-2,6-dimethylbenzene

1-Acetoxy-3-(N-acetyl-2-acetoxyethylamino)-5-methoxy-2,6-dimethylbenzene

C17H23NO6 (337.1525)


   

N-Trimethylsilylphenylacetylglycine trimethylsilyl ester

N-Trimethylsilylphenylacetylglycine trimethylsilyl ester

C16H27NO3Si2 (337.1529)


   

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

C20H21N2O3 (337.1552)


Conjugate base of (3Z,5S)-3-(1-hydroxyethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione arising from deprotonation of the enolic hydroxy group; major species at pH 7.3.

   

4-ethylidene-7-hydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

4-ethylidene-7-hydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

C17H23NO6 (337.1525)


   

3-[(2z)-4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

3-[(2z)-4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

C17H23NO6 (337.1525)


   

3-(4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene)-2-methylpropanimidic acid

3-(4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene)-2-methylpropanimidic acid

C17H23NO6 (337.1525)